These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28964324)

  • 1. Coffee consumption is not associated with prevalent subclinical cardiovascular disease (CVD) or the risk of CVD events, in nonalcoholic fatty liver disease: results from the multi-ethnic study of atherosclerosis.
    Simon TG; Trejo MEP; Zeb I; Frazier-Wood AC; McClelland RL; Chung RT; Budoff MJ
    Metabolism; 2017 Oct; 75():1-5. PubMed ID: 28964324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis.
    Simon TG; Trejo MEP; McClelland R; Bradley R; Blaha MJ; Zeb I; Corey KE; Budoff MJ; Chung RT
    Int J Cardiol; 2018 May; 259():198-204. PubMed ID: 29579601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of diabetes on subclinical atherosclerosis and major cardiovascular events in individuals with and without non-alcoholic fatty liver disease.
    Wang B; Zhao Z; Liu S; Wang S; Chen Y; Xu Y; Xu M; Wang W; Ning G; Li M; Wang T; Bi Y
    Diabetes Res Clin Pract; 2021 Jul; 177():108873. PubMed ID: 34051282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Al Rifai M; Silverman MG; Nasir K; Budoff MJ; Blankstein R; Szklo M; Katz R; Blumenthal RS; Blaha MJ
    Atherosclerosis; 2015 Apr; 239(2):629-33. PubMed ID: 25683387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study.
    VanWagner LB; Ning H; Lewis CE; Shay CM; Wilkins J; Carr JJ; Terry JG; Lloyd-Jones DM; Jacobs DR; Carnethon MR
    Atherosclerosis; 2014 Aug; 235(2):599-605. PubMed ID: 24956534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary prevention.
    Alfaddagh A; Kapoor K; Dardari ZA; Bhatt DL; Budoff MJ; Nasir K; Miller M; Welty FK; Miedema MD; Shapiro MD; Tsai MY; Blumenthal RS; Blaha MJ
    Atherosclerosis; 2022 Jul; 353():11-19. PubMed ID: 35759823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic Fatty Liver Disease Is Associated With Arterial Distensibility and Carotid Intima-Media Thickness: (from the Multi-Ethnic Study of Atherosclerosis).
    Oni E; Budoff MJ; Zeb I; Li D; Veledar E; Polak JF; Blankstein R; Wong ND; Blaha MJ; Agatston A; Blumenthal RS; Nasir K
    Am J Cardiol; 2019 Aug; 124(4):534-538. PubMed ID: 31262497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease and progression of coronary artery calcium score: a retrospective cohort study.
    Sinn DH; Kang D; Chang Y; Ryu S; Gu S; Kim H; Seong D; Cho SJ; Yi BK; Park HD; Paik SW; Song YB; Lazo M; Lima JA; Guallar E; Cho J; Gwak GY
    Gut; 2017 Feb; 66(2):323-329. PubMed ID: 27599521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of coronary artery calcium score for the prediction of atherosclerotic cardiovascular disease in participants with suspected nonalcoholic hepatic steatosis: Results from the multi-ethnic study of atherosclerosis.
    Ichikawa K; Hansen S; Manubolu VS; Pourafkari L; Fazlalizadeh H; Aldana-Bitar J; VanWagner LB; Krishnan S; Budoff MJ
    Am Heart J; 2023 Nov; 265():104-113. PubMed ID: 37517431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Associations of Nonalcoholic Fatty Liver Disease and Metabolic Dysfunction-Associated Fatty Liver Disease With Coronary Artery Calcification: A Cross-Sectional and Longitudinal Cohort Study.
    Sung KC; Yoo TK; Lee MY; Byrne CD; Zheng MH; Targher G
    Arterioscler Thromb Vasc Biol; 2023 Mar; 43(3):482-491. PubMed ID: 36727522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.
    Mikolasevic I; Milic S; Racki S; Zaputovic L; Stimac D; Radic M; Markic D; Orlic L
    Perit Dial Int; 2016; 36(4):427-32. PubMed ID: 26475841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty Liver Index as a proxy for non-alcoholic fatty liver disease and the risk of stroke and coronary heart disease: The Suita Study.
    Arafa A; Kashima R; Matsumoto C; Kokubo Y
    J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107495. PubMed ID: 38000108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes.
    Mantovani A; Mingolla L; Rigolon R; Pichiri I; Cavalieri V; Zoppini G; Lippi G; Bonora E; Targher G
    Int J Cardiol; 2016 Dec; 225():387-391. PubMed ID: 27768965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Greater Volume but not Higher Density of Abdominal Aortic Calcium Is Associated With Increased Cardiovascular Disease Risk: MESA (Multi-Ethnic Study of Atherosclerosis).
    Forbang NI; Michos ED; McClelland RL; Remigio-Baker RA; Allison MA; Sandfort V; Ix JH; Thomas I; Rifkin DE; Criqui MH
    Circ Cardiovasc Imaging; 2016 Nov; 9(11):. PubMed ID: 27903540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study.
    Lee H; Lee YH; Kim SU; Kim HC
    Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2138-2147.e10. PubMed ID: 33348045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between non-alcoholic fatty liver disease and subclinical coronary atherosclerosis: An observational cohort study.
    Lee SB; Park GM; Lee JY; Lee BU; Park JH; Kim BG; Jung SW; Jeong ID; Bang SJ; Shin JW; Park NH; Yang DH; Kang JW; Lim TH; Kim HK; Choe J; Lee HC
    J Hepatol; 2018 May; 68(5):1018-1024. PubMed ID: 29274406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic fatty liver disease is associated with cardiovascular disease in subjects with different glucose tolerance.
    Fiorentino TV; Succurro E; Sciacqua A; Andreozzi F; Perticone F; Sesti G
    Diabetes Metab Res Rev; 2020 Nov; 36(8):e3333. PubMed ID: 32356922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease.
    Arvind A; Henson JB; Osganian SA; Nath C; Steinhagen LM; Memel ZN; Donovan A; Balogun O; Chung RT; Simon TG; Corey KE
    Hepatol Commun; 2022 Feb; 6(2):309-319. PubMed ID: 34558862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very High Coronary Artery Calcium (≥1000) and Association With Cardiovascular Disease Events, Non-Cardiovascular Disease Outcomes, and Mortality: Results From MESA.
    Peng AW; Dardari ZA; Blumenthal RS; Dzaye O; Obisesan OH; Iftekhar Uddin SM; Nasir K; Blankstein R; Budoff MJ; Bødtker Mortensen M; Joshi PH; Page J; Blaha MJ
    Circulation; 2021 Apr; 143(16):1571-1583. PubMed ID: 33650435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe, but not mild to moderate, non-alcoholic fatty liver disease associated with increased risk of subclinical coronary atherosclerosis.
    Hsiao CC; Teng PH; Wu YJ; Shen YW; Mar GY; Wu FZ
    BMC Cardiovasc Disord; 2021 May; 21(1):244. PubMed ID: 34011282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.